Sonoma Pharmaceuticals (SNOA) Other Non-Current Assets (2011 - 2025)

Sonoma Pharmaceuticals' Other Non-Current Assets history runs 15 years deep, the most recent figure standing at $64000.0 for Q4 2025.

• In Q4 2025, Other Non-Current Assets fell 12.33% year-over-year to $64000.0; the TTM figure through Dec 2025 stood at $64000.0 (down 12.33% YoY), while the FY2025 annual figure was $74000.0, up 12.12% from the prior year.
• Other Non-Current Assets was $64000.0 for Q4 2025 at Sonoma Pharmaceuticals, down from $84000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $308000.0 in Q4 2022 to a low of $61000.0 in Q2 2024.
• Historically, Other Non-Current Assets has averaged $99650.0 across 5 years, with a median of $76500.0 in 2021.
• The sharpest annual moves came in 2021 and 2022: Other Non-Current Assets slumped 84.09% in 2021, then jumped 310.67% in 2022.
• A 5-year view of Other Non-Current Assets shows it stood at $75000.0 in 2021, then surged by 310.67% to $308000.0 in 2022, then slumped by 74.68% to $78000.0 in 2023, then slipped by 6.41% to $73000.0 in 2024, then dropped by 12.33% to $64000.0 in 2025.
• The last three Other Non-Current Assets figures came in at $64000.0 (Q4 2025), $84000.0 (Q3 2025), and $80000.0 (Q2 2025), per Business Quant data.